Notice of Proposed Sale · 144
Glaukos Corporation
GKOSNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- GLAUKOS Corp
- Issuer CIK
- 0001192448
- SEC file number
- 001-37463
- Phone
- 949-367-9600
- Person for whose account securities are to be sold
- Navratil Tomas
- Relationships to issuer
- Officer
- Street
- 1 GLAUKOS WAY
- City
- ALISO VIEJO
- State / country code
- CA
- Postal code
- 92656
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 1,615 | 249,157.98 | 58,983,937 | 09/25/2026 | NYSE | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 03/22/2025 | Restricted Stock Vesting | Issuer | 1,615 | N | 03/22/2025 | Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Tomas Navratil | Common | 07/01/2026 | 716 | 99,566.96 |
| Tomas Navratil | Common | 08/28/2026 | 13,744 | 2,483,097.96 |
| Tomas Navratil | Common | 09/16/2026 | 1,457 | 243,207.31 |
Seller — prior-sale row 1, entry 1
- Name
- Tomas Navratil
- Street
- 1 Glaukos Way
- City
- Aliso Viejo
- State / country code
- CA
- Postal code
- 92656
Seller — prior-sale row 2, entry 1
- Name
- Tomas Navratil
- Street
- 1 Glaukos Way
- City
- Aliso Viejo
- State / country code
- CA
- Postal code
- 92656
Seller — prior-sale row 3, entry 1
- Name
- Tomas Navratil
- Street
- 1 Glaukos Way
- City
- Aliso Viejo
- State / country code
- CA
- Postal code
- 92656
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 09/25/2026
- Signed
- /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Tomas Navratil
- Plan adoption dates
- 06/12/2026
Company context
Glaukos (www.glaukos.com) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012. In 2024, Glaukos commenced commercial launch activities for iDose® TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical designed to deliver 24/7 glaucoma drug therapy inside the eye for extended periods of time. Glaukos also markets the only FDA-approved corneal cross-linking therapy utilizing a proprietary bio-activated pharmaceutical for the treatment of keratoconus, a rarely diagnosed corneal disorder. Glaukos continues to successfully develop and advance a robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.